TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CIGNA PATHWELL

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CIGNA PATHWELL

ST13

US500000097037992

Classe

35, 36, 44

Pedido

97037992

Registro

7706750

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

30

Atualização mais recente

25/02/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

35, 36, 44

Data de depósito

21/09/2021

Data de registro

25/02/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

25/02/2025

Última transação

25/02/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

01/06/2022

Primeiro uso no comércio

01/06/2022

Código do desenho

4

Tipo de titular

03

Localização do titular

Willmington, DE, US

Examinador

AREY, BRANDON LEON

Unidade examinadora

N90

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Cigna Intellectual Property, Inc.

Representantes

Cigna Intellectual Property, Inc.

Classificação técnica

Classes Nice

Classe 35Classe 36Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

Cost management for the healthcare benefit and prescription drug benefit plans of others in the field of pharmaceuticals; business services, namely, pharmaceutical cost management services and drug utilization review services for the prescription drug and medical formulary plans of others; consulting services regarding healthcare costs management and retail pharmacy services; Drug utilization review services and drug and medical formulary cost management services; pharmaceutical and medical cost management services and drug utilization review services; in-network provider advisory services and consultancy services, strategic business analysis and business advice in the field of medical insurance regarding pharmacy benefit management and medical benefit management; business data analysis regarding health care benefit plan pharmaceutical end-user behavior and health care benefit plan healthcare use behavior; market study and analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level; providing business intelligence services in the field of pharmacy benefit management; administration of employee benefit plans concerning pharmacy benefit plans; cost management for pharmacy and heath care benefit services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits to identify potential cost savings

Classe 36

Pharmacy benefit management services; pharmacy benefit management consulting services; medical benefit management services concerning insurance; advisory services and consultancy regarding medical insurance healthcare benefits, in-network coverage and pharmacy benefits; provision of information and analysis in the fields of healthcare plan benefits and pharmacy benefits; prescription health care benefit coverage plans services, namely, providing insurance underwriting and claims administration of prescription drug plans for qualified beneficiaries; administration of pharmacy benefit plans concerning insurance; pharmacy benefit management services concerning insurance, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits, all to identify clinical benefits; prescription drug and healthcare benefit plan services, namely, providing information to patients regarding in-network services in the fields of disease management programs and chronic conditions

Classe 44

Advisory services and consultancy regarding healthcare; healthcare services, namely, wellness and disease management programs for patients; health care services, namely, disease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance and providing healthcare and medical information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcare and pharmaceuticals; providing information in the field of healthcare to pharmacy benefit management services clients, consultants and brokers

Publicações

Histórico de despachos e eventos da marca no USPTO.

30 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

25/02/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

25/02/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/02/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/02/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

18/12/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

14/12/2024

IUAF

USE AMENDMENT FILED

03/10/2024

EISU

TEAS STATEMENT OF USE RECEIVED

03/10/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

29/02/2024

EX2G

SOU EXTENSION 2 GRANTED

28/02/2024

EXT2

SOU EXTENSION 2 FILED

28/02/2024

EEXT

SOU TEAS EXTENSION RECEIVED

28/02/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/10/2023

EX1G

SOU EXTENSION 1 GRANTED

29/09/2023

EXT1

SOU EXTENSION 1 FILED

29/09/2023

EEXT

SOU TEAS EXTENSION RECEIVED

29/09/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/04/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/02/2023

PUBO

PUBLISHED FOR OPPOSITION

07/02/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

18/01/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/01/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

15/12/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

15/12/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

15/12/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/07/2022

GNRT

NON-FINAL ACTION E-MAILED

05/07/2022

CNRT

NON-FINAL ACTION WRITTEN

05/07/2022

DOCK

ASSIGNED TO EXAMINER

23/06/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

24/10/2021

NWAP

NEW APPLICATION ENTERED

24/09/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CIGNA PATHWELL ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.